Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography, Transesophageal | 2 | 2012 | 117 | 0.610 |
Why?
|
| Prostatic Neoplasms | 5 | 2023 | 501 | 0.520 |
Why?
|
| Robotic Surgical Procedures | 3 | 2023 | 172 | 0.430 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2009 | 272 | 0.420 |
Why?
|
| Hypoxia | 1 | 2012 | 121 | 0.330 |
Why?
|
| Heart-Assist Devices | 1 | 2012 | 158 | 0.300 |
Why?
|
| Hemangioma, Cavernous | 1 | 2009 | 9 | 0.300 |
Why?
|
| Ultrasonography, Interventional | 2 | 2021 | 124 | 0.300 |
Why?
|
| Hemangioma, Capillary | 1 | 2009 | 3 | 0.300 |
Why?
|
| Heart Neoplasms | 1 | 2009 | 36 | 0.290 |
Why?
|
| Hydrogels | 2 | 2020 | 127 | 0.270 |
Why?
|
| Coagulants | 1 | 2007 | 3 | 0.260 |
Why?
|
| Factor VIIa | 1 | 2007 | 4 | 0.260 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2007 | 59 | 0.260 |
Why?
|
| Postoperative Hemorrhage | 1 | 2007 | 41 | 0.250 |
Why?
|
| Cooking and Eating Utensils | 1 | 2006 | 2 | 0.240 |
Why?
|
| Academies and Institutes | 1 | 2006 | 24 | 0.230 |
Why?
|
| Actinomycosis | 1 | 2004 | 5 | 0.220 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2016 | 66 | 0.210 |
Why?
|
| Urinary Tract Infections | 1 | 2004 | 97 | 0.200 |
Why?
|
| Prostatectomy | 2 | 2023 | 104 | 0.200 |
Why?
|
| Cryosurgery | 1 | 2022 | 28 | 0.180 |
Why?
|
| Robotics | 1 | 2022 | 86 | 0.170 |
Why?
|
| Ultrasonics | 1 | 2021 | 19 | 0.170 |
Why?
|
| Consensus | 1 | 2021 | 177 | 0.160 |
Why?
|
| Perioperative Care | 1 | 2020 | 87 | 0.150 |
Why?
|
| Rectal Diseases | 1 | 2019 | 29 | 0.150 |
Why?
|
| Ultrasonography | 1 | 2021 | 491 | 0.140 |
Why?
|
| Joint Capsule Release | 1 | 2018 | 2 | 0.140 |
Why?
|
| Societies, Medical | 1 | 2021 | 400 | 0.140 |
Why?
|
| Patient Admission | 1 | 2020 | 200 | 0.140 |
Why?
|
| Dilatation | 1 | 2018 | 34 | 0.140 |
Why?
|
| Arthroscopy | 1 | 2018 | 34 | 0.140 |
Why?
|
| Manikins | 1 | 2018 | 22 | 0.140 |
Why?
|
| Bursitis | 1 | 2018 | 18 | 0.140 |
Why?
|
| Ambulatory Care | 1 | 2020 | 318 | 0.130 |
Why?
|
| Anesthesiology | 1 | 2018 | 41 | 0.130 |
Why?
|
| Radiology | 1 | 2021 | 263 | 0.120 |
Why?
|
| Aminocaproic Acid | 1 | 2016 | 3 | 0.120 |
Why?
|
| Male | 12 | 2023 | 31292 | 0.120 |
Why?
|
| Humans | 18 | 2023 | 65645 | 0.120 |
Why?
|
| High-Energy Shock Waves | 1 | 2015 | 5 | 0.120 |
Why?
|
| Achilles Tendon | 1 | 2015 | 8 | 0.120 |
Why?
|
| Laparoscopy | 1 | 2020 | 492 | 0.110 |
Why?
|
| Tendinopathy | 1 | 2015 | 11 | 0.110 |
Why?
|
| Adult | 7 | 2023 | 17511 | 0.100 |
Why?
|
| Hemorrhage | 1 | 2016 | 286 | 0.100 |
Why?
|
| Granuloma | 1 | 2014 | 43 | 0.100 |
Why?
|
| Shock, Cardiogenic | 1 | 2015 | 108 | 0.100 |
Why?
|
| Spinal Fractures | 1 | 2014 | 41 | 0.100 |
Why?
|
| Thrombosis | 1 | 2016 | 207 | 0.100 |
Why?
|
| Databases, Factual | 3 | 2022 | 888 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2018 | 731 | 0.100 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2014 | 145 | 0.090 |
Why?
|
| Antirheumatic Agents | 1 | 2014 | 227 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2018 | 802 | 0.080 |
Why?
|
| Injections | 2 | 2020 | 84 | 0.080 |
Why?
|
| Hypogonadism | 1 | 2008 | 15 | 0.070 |
Why?
|
| Androgen Antagonists | 1 | 2008 | 32 | 0.070 |
Why?
|
| Middle Aged | 7 | 2023 | 18439 | 0.070 |
Why?
|
| Androgens | 1 | 2008 | 67 | 0.070 |
Why?
|
| Metabolic Diseases | 1 | 2008 | 59 | 0.070 |
Why?
|
| Heart Ventricles | 1 | 2009 | 267 | 0.060 |
Why?
|
| Safety | 1 | 2007 | 142 | 0.060 |
Why?
|
| Emergencies | 1 | 2007 | 124 | 0.060 |
Why?
|
| Patient Safety | 2 | 2020 | 281 | 0.060 |
Why?
|
| Electrocardiography | 1 | 2009 | 555 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2018 | 3329 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 708 | 0.060 |
Why?
|
| Female | 7 | 2018 | 34309 | 0.050 |
Why?
|
| Adolescent | 2 | 2023 | 6350 | 0.050 |
Why?
|
| Research Design | 1 | 2006 | 590 | 0.050 |
Why?
|
| Nephrectomy | 1 | 2022 | 93 | 0.050 |
Why?
|
| Prostate | 1 | 2023 | 124 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 92 | 0.040 |
Why?
|
| Musculoskeletal System | 1 | 2021 | 10 | 0.040 |
Why?
|
| United Kingdom | 1 | 2021 | 86 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2023 | 931 | 0.040 |
Why?
|
| Matched-Pair Analysis | 1 | 2020 | 11 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 872 | 0.040 |
Why?
|
| Young Adult | 2 | 2023 | 4855 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2022 | 6948 | 0.040 |
Why?
|
| Length of Stay | 1 | 2022 | 828 | 0.040 |
Why?
|
| Medical Errors | 1 | 2021 | 202 | 0.040 |
Why?
|
| Radiation Injuries | 1 | 2019 | 67 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2022 | 521 | 0.040 |
Why?
|
| Triamcinolone | 1 | 2018 | 3 | 0.040 |
Why?
|
| Visual Analog Scale | 1 | 2018 | 10 | 0.030 |
Why?
|
| Lidocaine | 1 | 2018 | 33 | 0.030 |
Why?
|
| Injections, Intra-Articular | 1 | 2018 | 52 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2018 | 69 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 2018 | 65 | 0.030 |
Why?
|
| Shoulder Joint | 1 | 2018 | 33 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2018 | 56 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 2018 | 73 | 0.030 |
Why?
|
| United States | 2 | 2022 | 8166 | 0.030 |
Why?
|
| Radiography, Interventional | 1 | 2018 | 83 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 2730 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2018 | 190 | 0.030 |
Why?
|
| Aged | 3 | 2023 | 15089 | 0.030 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2016 | 15 | 0.030 |
Why?
|
| Antifibrinolytic Agents | 1 | 2016 | 19 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2022 | 1335 | 0.030 |
Why?
|
| Etanercept | 1 | 2014 | 33 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2014 | 64 | 0.030 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2014 | 62 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2014 | 195 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 1715 | 0.020 |
Why?
|
| Biopsy | 1 | 2014 | 460 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 472 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 273 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2496 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1227 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2008 | 39 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2008 | 38 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 3777 | 0.020 |
Why?
|
| Osteoporosis | 1 | 2008 | 113 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 5656 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2008 | 415 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 5820 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 5466 | 0.010 |
Why?
|